Flortaucipir F18

(Tauvid®)

Flortaucipir F18

Drug updated on 5/9/2024

Dosage FormInjection (intravenous; 300 MBq/mL to 1,900 MBq/mL [8.1 mCi/mL to 51 mCi/mL] of flortaucipir F 18 injection in a multiple-dose vial)
Drug ClassRadioactive diagnostic agents
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD).